Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials

Statistics in Medicine

Volumn 28, Issue 17, 2009, Pages 2185-2201

  Brutti, Pierpaolo ^a   De Santis, Fulvio ^b   Gubbiotti, Stefania ^b  

^a LUISS UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Analysis prior; Design prior; Phase II and Phase III clinical trials; Sample size determination; Sample size re estimation

Indexed keywords

MAGNESIUM SULFATE; PLACEBO; TAMOXIFEN;

ACUTE HEART INFARCTION; ARTICLE; BAYESIAN LEARNING; BREAST CANCER; CANCER RECURRENCE; CLINICAL TRIAL; CONCEPTUAL FRAMEWORK; HUMAN; INFORMATION PROCESSING; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEDICAL RESEARCH; METHODOLOGY; PREDICTION; RELIABILITY; SAMPLE SIZE;

BAYES THEOREM; BIOMETRY; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MAGNESIUM SULFATE; MODELS, STATISTICAL; MONTE CARLO METHOD; MYOCARDIAL INFARCTION; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 69949099954     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3609     Document Type: Article

References (23)

1. Chaloner K, Verdinelli I. Bayesian experimental design: a review. Statistical Science 1995; 10:237-308.
2. Das Gupta A. Review of optimal Bayes designs. Design and Analysis of Experiments. Handbook of Statistics, vol. 13. Elsevier: Amsterdam, 1996; 1099-1147.
3. Joseph L, Belisle P. Bayesian sample size determination for normal means and difference between normal means. The Statistician 1997; 46:209-226.
4. Clarke BS, Yuan A. A closed form expression for Bayesian sample sizes. Annals of Statistics 2006; 34(3): 1293-1330. DOI: 10.1214/ 009053606000000308.
5. De Santis F. Using historical data for Bayesian sample size determination. Journal of the Royal Statistical Society, Series A 2007; 170(1):95-113.
6. Gajewski BJ, Mayo MS. Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors. Statistics in Medicine 2006; 25:2554-2566. DOI: 10.1002/sim.2450.
7. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research (4th edn). Blackwell Science: Oxford, 2002.
8. Tan SB, Machin D. Bayesian two-stage designs for phase II clinical trials. Statistics in Medicine 2002; 21: 1991-2012. DOI: 10.1002/sim.1176.
9. Mayo MS, Gajewski BJ. Bayesian sample size calculations in phase II clinical trials using informative conjugate priors. Controlled Clinical 2004; 25(2):157-167. DOI: 10.1016/j.cct.2003.11.006.
10. De Santis F. Sample size determination for robust Bayesian analysis. Journal of the American Statistical Association 2006; 101(473):278-291. DOI: 10.1198/016214505000000510.
11. Tsutakawa RK. Design of experiment for bioassay. Journal of the American Statistical Association 1972; 67:585-590.
12. Etzioni R, Kadane JB. Optimal experimental design for anothers analysis. Journal of the American Statistical Association 1993; 88 (424):1404-1411.
13. Wang MD, Gelfand AE. A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models. Statistical Science 2002; 17(2):193-208. DOI: 10.1214/ss/1030550861.
14. O'Hagan A, Stevens JW. Bayesian assessment of sample size for clinical trials for cost effectiveness. Medical Decision Making 2001; 21:219-230. DOI: 10.1177/02729890122062514.
15. Sahu SK, Smith TMF. A Bayesian method of sample size determination with practical applications. Journal of the Royal Statistical Society, Series A (Statistics in Society) 2006; 169(2):235-253. DOI: 10.1111/j.1467-985X.2006.00408.x.
16. Brutti P, De Santis F. Avoiding the range of equivalence in Clinical trials: robust Bayesian sample size determination for credible intervals. Journal of Statistical Planning and Inference 2008; 138:1577-1591. DOI: 10.1016/j.jspi.2007.05.041.
17. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-care Evaluation. Wiley: New York, 2004.
18. Spiegelhalter DJ, Freedman LS. A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Statistics in Medicine 1986; 5:1-13.
19. Joseph L, du Berger R, Belisle P. Bayesian and mixed Bayesian/likelihood criteria for sample size determination. Statistics in Medicine 1997; 16(7):769-781.
20. Brutti P, De Santis F, Gubbiotti S. Robust Bayesian sample size determination in clinical trials. Statistics in Medicine 2008; DOI: 10.1002/sim.3175.
21. Ibrahim JG, Chen MH. Power prior distributions for regression models. Statistical Science 2000; 15(1):46-60.
22. Wang MD. Sample size re-estimation by Bayesian prediction. Biometrical Journal 2006; 48(5):1-13. DOI: 10.1002/ bimj.200510273.
23. Dignam JJ, Bryant J, Wieand HS, Fisher B, Wolmark N. Early stopping of a clinical trial when there is evidence of no treatment benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project. Controlled Clinical Trials 1998; 19:575-588.